ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "IgG"

  • 2018 American Transplant Congress

    Multi-Targeting Desensitization Therapy Alters Peripheral B-Cell Homeostasis and Suppresses Recall Alloantibody Responses

    I. Kim, G. Wu, N-.N. Chai, A. Klein, S. Jordan.

    CTC/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Purpose: Occurring of donor specific antibodies (DSA) is injurious to organ transplant. Development of immunotherapies to suppress DSA, therefore, has been one of the strategic…
  • 2018 American Transplant Congress

    Long Term Culture of Functional Bone Marrow-Derived Human Plasma Cells

    N. Moore, K. Bonner, M. D'Costa, M. Stegall.

    William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.

    Introduction Antibody-secreting plasma cells (PCs) are critically important for host defense, but also can cause antibody-mediated allograft rejection. The ability to study these cells is…
  • 2017 American Transplant Congress

    Is There Any Difference Between ABO-Incompatible and ABO-Compatible Liver Transplantation? Oncologic Aspect.

    J. Lee,1 J. Lee,1 S. Song,1 S.-K. Kwon,1 D. Kim,1 J. Lee,2 M. Kim,1 G. Choi,1 J. Choi,1 D. Han,1 S. Kim,1 D. Joo.1

    1Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; 2Department of Surgery, CHA University, Bundang, Korea

    Introduction: Liver transplantation (LT) is increasing treatment option for hepatocellular carcinoma (HCC) in East Asia. Over-immunosuppression is risk factor for oncologic outcome after transplantation and…
  • 2017 American Transplant Congress

    IgG Antibody Subclasses in Potential Renal Transplant Recipients with DSA, AHG-CDC CxM Negative and FxM Positive or Negative with Their Potential Donors.

    A. Contreras, A. Casillas, L. Llorente, G. Lima, A. Arvizu, A. De Santiago, M. Vilatoba, J. Alberu, J. Arreola-Guerra.

    Transplantation Departament, 1b Immunology Department, Inst Nal Ciencia Medicas y Nutricion SZ, Mexico City, Mexico

    Background. In kidney transplant recipients, IgG3 and IgG4 DSA have been associated with shorter time to acute AMR and with later allograft injury (glomerulopathy &…
  • 2017 American Transplant Congress

    Daratumumab for Severe Refractory Proliferative Glomerulonephritis with Monoclonal Immune Deposits (PGNMID).

    S. Anand,1,3 D. Miller,1 G. Chipman,2 D. Morris,1,3 T. Srinivas.1

    1Intermountain Medical Center, Salt Lake City, UT; 2Utah Cancer Specialists, Salt Lake City, UT; 3Nephrology Assoxiates of Utah, Salt Lake CIty, UT

    Introduction-We report as case of refractory PGNMID treated succesfully with anti-CD38 antibody (Daratumumab). Case report-65 year old male with ESRD attributed to to post infectious…
  • 2017 American Transplant Congress

    Detection of Specific B Cell Memory to the Perlecan LG3 Antigen in the Normal Immune Repertoire.

    L. Padet,1,2,3 M. Dieude,1,2 B. Yang,1,2,3 J. Turgeon,1,2 H. Cardinal,1,2 M.-J. Hebert.1,2,3

    1Research Center of Montreal Hospital Center (CRCHUM), Montreal, Canada; 2Canadian National Transplant Research Program (CNTRP), Edmunton, Canada; 3Université de Montréal, Montreal, Canada

    Autoantibodies targeting the C-terminal fragment of perlecan (LG3) were identified in patients with kidney transplantation and are associated with rejection episodes. High anti-LG3 titers were…
  • 2017 American Transplant Congress

    Development of an Anti-HLA Antibody-Producing Humanized Mouse Model.

    S. Yanagawa, H. Tahara, H. Ohdan.

    Hiroshima University, Hiroshima, Japan; Hiroshima University, Hiroshima, Japan; Hiroshima University, Hiroshima, Japan

    Chronic antibody-mediated rejection due to anti-human leukocyte antigen (HLA) antibodies (Abs) is an important problem in organ transplantation. The spleen has been reported to be…
  • 2017 American Transplant Congress

    BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study.

    H. Hirsch,1 C. Leboeuf,1 S. Wilk,1 R. Achermann,2 I. Binet,3 D. Golshayan,2 K. Hadaya,2 C. Hirzel,2 M. Hoffmann,2 U. Huynh-Do,2 M. Koller,2 O. Manuel,2 N. Mueller,2 T. Mueller,2 S. Schaub,2 C. Van Delden,2 F. Weissbach.1

    1University of Basel, Basel, Switzerland; 2Swiss Transplant Cohort Study, Basel, Switzerland; 3Cantonal Hospital St Gallen, St Gallen, Switzerland

    BK polyomavirus (BKPyV) causes premature kidney transplant (KT) failure in 1-15% of patients. Since antivirals are lacking, most programs screen KT patients for BKPyV viremia…
  • 2017 American Transplant Congress

    CD8+ TAb-supp Cells Suppress the Production of Multiple Alloantibody Isotypes in Response to MHC-Mismatched Cellular and Vascularized Allografts.

    J. Zimmerer, C. Avila, S. Elzein, B. Ringwald, G. Bumgardner.

    Surgery, The Ohio State University Wexner Medical Center, Columbus, OH

    We have reported that a CD8+ T cell subset, we termed CD8+ TAb-supp cells, inhibits the production of alloAb after hepatocyte transplant (HcTx) in part…
  • 2017 American Transplant Congress

    IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-CMV IgG, Resulting in Inhibition of Antibody (Ab)-Mediated NK Cell Activation in Kidney Transplant Patients (KTX Pts).

    B.-H. Shin,1 S. Ge,1 M. Chu,1 J. Choi,1 L. Winstedt,2 C. Kjellman,2 S. Louie,1 A. Vo,1 A. Peng,1 S. Jordan,1 M. Toyoda.1

    1Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Hansa Medical, Lund, Sweden

    Background: Viral infections represent significant morbidity factors for KTx Pts. Ab-dependent cell-mediated cytotoxicity (ADCC) is a major pathway to eliminate virally infected cells and is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences